Russell J. Wiese - Concepedia

Author

Russell J. Wiese

Eli Lilly (United States)ORCID

Also Known As

McGuire, Darren K, R J Wiese, R. Wiese, R.J. Wiese, Russell J Wiese, Russell J. Wiese, Russell John Wiese

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of Washington University of Wisconsin–Madison University of Toronto University of Groningen

About

Russell J. Wiese is an author at Eli Lilly (United States) specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.9K
2	Engineering	1	1	135
3	Natural Sciences	1	1	18
4	Biochemistry	1	1	18
5	Biomedical Engineering	1	1	135

Russell J. Wiese

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial Stefano Del Prato, Steven E. Kahn, Imre Pávó, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseMedicineInsulin Management	2021	586
Mitogen-activated Protein Kinase Kinase Inhibition Does Not Block the Stimulation of Glucose Utilization by Insulin Dan Lazar, Russell J. Wiese, Matthew Brady, Journal of Biological Chemistry	1995	399
The Cardiac Tissue-Restricted Homeobox Protein Csx/Nkx2.5 Physically Associates with the Zinc Finger Protein GATA4 and Cooperatively Activates Atrial Natriuretic Factor Gene Expression Youngsook Lee, Tetsuo Shioi, Hideko Kasahara, Molecular and Cellular Biology Cardiac MuscleCardiomyopathyMolecular PhysiologyCardiac ReprogrammingDevelopmental Biology	1998	273
The Transcription Factor GATA4 Is Activated by Extracellular Signal-Regulated Kinase 1- and 2-Mediated Phosphorylation of Serine 105 in Cardiomyocytes Qiangrong Liang, Russell J. Wiese, Orlando F. Bueno, Molecular and Cellular Biology Cardiac MuscleTranscriptional RegulationCardiomyopathyMolecular PhysiologySignal Transduction	2001	263
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial Hiddo J.L. Heerspink, Naveed Sattar, Imre Pávó, The Lancet Diabetes & Endocrinology Metabolic SyndromeDiabetes ManagementInsulin ManagementChronic Kidney DiseaseDiabetes	2022	252
Up-regulation of the vitamin D receptor in response to 1,25-dihydroxyvitamin D3 results from ligand-induced stabilization. Russell J. Wiese, Ann Uhland‐Smith, T K Ross, Journal of Biological Chemistry Molecular PharmacologyLigand-induced StabilizationDegradation RateSignal TransductionGastrointestinal Peptide Hormone	1992	221
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics Stephen J. Nicholls, Deepak L. Bhatt, John B. Buse, American Heart Journal	2023	194
Activation of Mitogen-activated Protein Kinase and Phosphatidylinositol 3′-Kinase Is Not Sufficient for the Hormonal Stimulation of Glucose Uptake, Lipogenesis, or Glycogen Synthesis in 3T3-L1 Adipocytes Russell J. Wiese, Cynthia Corley Mastick, Dan Lazar, Journal of Biological Chemistry	1995	152
Ubiquitous GFP expression in transgenic chickens using a lentiviral vector Susan C. Chapman, Aaron Lawson, William C. MacArthur, Development EngineeringImmunologyUbiquitous Gfp ExpressionBiomedical EngineeringReproductive Biology	2005	135
Structure and regulation of the rat 1,25-dihydroxyvitamin D3 receptor. J. K. Burmester, Russell J. Wiese, Nobuo Maeda, Proceedings of the National Academy of Sciences Molecular PharmacologyMolecular PhysiologyMedicinePhysiologyImmunology	1988	116

Page 1